ConductScience.org, home

Paper4053271

Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma.

Gilchrist NL and 7 others. Cancer Chemother Pharmacol, 1985. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma. Papers, record 4053271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4053271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2019-08-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gilchrist NLN L
2Caldwell JJ
3Watson IDI D
4Cunningham DD
5Forrest GJG J
6Soukop MM
7Stewart MM
8Fitch WW

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LymphomaMajor topic
MethotrexateMajor topic
Adult
Creatinine
Female
Humans
Kinetics
Male
Middle Aged

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16610829Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion.N Engl J Med1984https://conductscience.org/library/papers/6610829PubMed
2832268The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.Cancer Res1977https://conductscience.org/library/papers/832268PubMed
36600902Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.Ann Intern Med1983https://conductscience.org/library/papers/6600902PubMed
4267510High-dose methotrexate in acute lymphocytic leukemia.Cancer Treat Rep1977https://conductscience.org/library/papers/267510PubMed
57011005Intrathecal methotrexate-induced neurotoxicities.Am J Hosp Pharm1981https://conductscience.org/library/papers/7011005PubMed
66600662Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.Clin Pharmacol Ther1983https://conductscience.org/library/papers/6600662PubMed
7806016Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.N Engl J Med1975https://conductscience.org/library/papers/806016PubMed
8433950Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy.Am J Med1979https://conductscience.org/library/papers/433950PubMed
95630481Pharmacology of methotrexate in the human central nervous system.Surg Gynecol Obstet1967https://conductscience.org/library/papers/5630481PubMed
107388786Active transport of methotrexate from cerebrospinal fluid in humans.Cancer Res1980https://conductscience.org/library/papers/7388786PubMed
116141424Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia.Lancet1984https://conductscience.org/library/papers/6141424PubMed
126782926Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.Ann Intern Med1981https://conductscience.org/library/papers/6782926PubMed
136344932Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients.Blood1983https://conductscience.org/library/papers/6344932PubMed
147370167Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro.Br J Cancer1980https://conductscience.org/library/papers/7370167PubMed
15510081The development of resistance to methotrexate in a mouse melanoma cell line. I. Characterisation of the dihydrofolate reductases and chromosomes in sensitive and resistant cells.Chromosoma1979https://conductscience.org/library/papers/510081PubMed
1613973811Subarachnoid distribution of drugs after lumbar injection.N Engl J Med1962https://conductscience.org/library/papers/13973811PubMed
176353235The pharmacology and clinical use of methotrexate.N Engl J Med1983https://conductscience.org/library/papers/6353235PubMed
185259150Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates.J Clin Invest1969https://conductscience.org/library/papers/5259150PubMed
196147703Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?Lancet1984https://conductscience.org/library/papers/6147703PubMed
204719662Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.J Clin Invest1973https://conductscience.org/library/papers/4719662PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
20737501Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate.Head Neck2012https://conductscience.org/library/papers/20737501PubMed
16928151Pharmacokinetic considerations in the treatment of CNS tumours.Clin Pharmacokinet2006https://conductscience.org/library/papers/16928151PubMed
9696379Current diagnosis and treatment of leptomeningeal metastasis.J Neurooncol1998https://conductscience.org/library/papers/9696379PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4053271

GET https://conductscience.org/api/papers/v1/4053271/authors